Acute infection by Toxoplasma gondii leads to suppression of cellmediated immunity, facilitating chronic infection. One of the causes of immunosuppression is Interleukin-10 (IL-10) production. Glucan is used to stimulate phagocytosis. Our objective was to study IL-10 induction in male BALB/c mice with acute T. gondii BTU-2 strain infection, glucan immunostimulation, and sulfadiazine treatment. Animals were distributed into 7 groups: G1: infected with T. gondii; G2: infected with T. gondii and treated with sulfadiazine; G3: infected with T. gondii and immunostimulated with glucan; G4: infected with T. gondii, immunostimulated with glucan, and treated with sulfadiazine; G5: imunostimulated with glucan; G6: treated with saline; and G7: treated with sulfadiazine. IL-10 levels were determined by ELISA; the highest levels were found in G2, G3 and G4, and the lowest in G1 (p<0.001). Groups G1 to G5 and G7 had substantially higher levels than G6 (p<0.001). In this study, the highest IL-10 levels were found in groups treated with glucan.
INTRODUCTION
Toxoplasma gondii is an obligate intracellular parasite with a wide geographical distribution. Under normal conditions it is asymptomatic, but in immunocompromised individuals, such as AIDS patients, the parasite can rapidly disseminate causing severe disease (35) .
The possibility that the parasite genotype influences the severity of the disease in humans is supported by differences in virulence observed in animal experimental models (30) . Toxoplasma gondii presents a highly clonal populational structure made up of three strains: types I, II and III (30) . T. gondii type I strain is extremely virulent, producing high levels of parasitemia, with increased risk of transplacentary transmission and increased severity of infection in developing fetuses, whereas types II and III strains lead to chronic infection and production of tissue cysts in mice (30) .
Da Silva et al. (9) described the BTU-2 strain originally isolated from a dog as a type III strain, although it shows high virulence to mice.
Sufadiazine and pyrimethamine are the two main drugs for treating toxoplasmosis (24) . They have a beneficial action when given in the acute phase of the disease, when there is active parasite multiplication; however they usually do not indicate infection. These drugs are believed to have little effect on subclinical infection, although the growth of tissue cysts in mice has been restrained with sulphonamides (27) . Other drugs such as diaminodiphenylsulphone, atovaquone, spiramycin, and clindamycin have also been used to treat difficult cases of toxoplasmosis (27) . In a recent work, Montoya et al. (43) reported that the most effective treatment is the combination of sulfadiazine, pyrimethamine, and folic acid. This controls disease in acutely infected patients, children with congenital infection, and immunocompromised individuals with ocular disease (43) .
Because immunity plays an important role in controlling acute toxoplasmosis, experimental models have often been used to analyse protective immune response against T. gondii (56). In both man and mice, acute T. gondii infection can suppress the immunological function (35) .
The interaction between natural killer (NK) cells, macrophages (26, 32) , Th1-type
CD4
+ T cells (20) , and antibodies (16) and IFN-γ levels produced during infection, they were not able to exert a protective (56), using C57BL/6 mice infected with ME49 strain, reported serious intestinal infection followed by death in IL-10 deficient animals; however, normal and IL-10 deficient mice treated with anti-IFN-γ antibody survived after infection without developing intestinal lesions. These results also suggest that IL-10 has a role in regulating elevated IFN-γ production levels, which can lead to animal death.
The β-glucans are polysaccharides found in the cell wall of different microorganisms, including bacteria and fungi, and also some cereals, such as oats and barley. Glucan The glucans stimulate the host system to exert a beneficial effect against bacterial, viral, fungal, and protozoal infections (42, 52, 59) . They modulate both humoral and cellular immunity; their efficiency has also been confirmed against tumors (39) and as hematopoiesis stimulator (28) .
There are reports on macrophage (57), neutrophil (51), and NK cell (14) Other studies have reported that intravenous administration of β-1,3 and β-1,6
polysaccharides, before infection with T. gondii RH strain in mice, increased animal survival. The authors suggest that the higher resistance to T. gondii may be due to the fact that glucans increase macrophage activation (47) . Similarly, a glucan protective effect has been demonstrated in experimental candidiasis (11) and human paracoccidioidomycosis (42) , and an adjuvant action was observed in experimental immunization against Leshmania donovani (29) .
The objective of this paper was to study IL-10 induction in BALB/c mice acutely infected by T. gondii, and treated with β-1,3 polyglucose and sulfadiazine.
MATERIALS AND METHODS

Mice
We used 150 male isogenic BALB/c mice, G2: (n=20) infected with T. gondii and treated with sulfadiazine.
G3: (n=20) infected with T. gondii and immunostimulated with glucan.
G4: (n=20) infected with T. gondii, immunostimulated with glucan, and treated with sulfadiazine.
G5: (n=20) not infected with T. gondii and immunostimulated with glucan.
G6: (n=20) not infected with T. gondii and treated with saline.
G7: (n=20) not infected with T. gondii and treated with sulfadiazine.
Infection with T. gondii
Mice were infected with tachyzoites of BTU-2 T. gondii, a type III strain that presents high virulence to mice (9) , from a naturally infected dog, kindly provided by the Zoonosis Service, Department of Veterinary Hygiene and Public Health, Botucatu
School of Veterinary Medicine and Animal Husbandry. Toxoplasma gondii strain was maintained in the laboratory by continuous intraperitoneal passage in BALB/c mice.
Tachyzoites were counted in a Newbauer chamber, 1x10 5 tachyzoites/ml saline. All mice in groups G1 to G4 were intraperitoneally infected with 0.1 ml inoculum on day zero.
Immunostimulation with glucan
Glucan was obtained from the University Hospital Hemocenter, Botucatu School of Medicine. It was manufactured from 3000 mg of bread yeast (S. cerevisae), divided into two lots, according to Di Luzio et al. (11) . To each lot, 2 L of 3% NaOH was added and boiled for 4h in water bath. The mixture was allowed to rest overnight; supernatant was then aspirated. This procedure was performed three to four times to obtain alkaline hydrolysis. Later, acid hydrolysis was performed by adding 2 L of 3%
HCL and boiling for 4h in water bath. The mixture was allowed to rest overnight and supernatant was then aspirated. This procedure was performed three to four times.
The precipitate was washed twice in distilled water and centrifuged. The resulting residues were washed in boiling water and then centrifuged. The residues in both recipients were resuspended in 1 L ethanol and kept at room temperature for a few intraperitoneally on days -7, -4, -1, +2, and +4.
Treatment with sulfadiazine
Two 500-mg sulphadiazine tablets were each dissolved in 45 ml of distilled water to obtain a concentration of 375 mg/kg/day. G2, G4, and G7 received a single dose by gavage of 0.5 ml/day of a suspension containing approximately 11 mg sulfadiazine on days +1, +2, +3, and +4.
Treatment with saline
G6 mice received 0.1 ml saline solution intraperitoneally on days -7, -4, -1, +2, and +4.
Determination of Interleukin-10
Blood samples were obtained by cardiac puncture on days -6, -4, -3, -1, and zero, from G5 and G6, and on days zero, +1, +2, +3, +4, and +5, from all groups. Sera were obtained after centrifugation (15 min at 1600 x g), aliquoted into 2-ml vials and kept at -70 º C until analysis. IL-10 serum levels were determined using ELISA kit (Catalog M1000, R&D Systems, Minneapolis, M.N.), according to the manufacturer's instructions. Detection limit was 4 pg/ml.
Statistical Analysis
The experiment was analysed in two stages, before and after infection with T. gondii.
Stage 1: before infection -Two groups, G5 (glucan) and G6 (saline) were evaluated at five different times: T1=-6; T2=-4; T3=-3; T4=-1; and T5=0 (day zero, infection day).
Stage 2: after infection -All seven groups, G1 (T. gondii); G2 (T. gondii + sulpha); G3 (T. gondii + glucan); G4 (T. gondii + glucan + sulpha); G5 (glucan); G6 (saline), and 
RESULTS
There was no alteration in G6 pre-infection IL-10 serum levels at all five times (Stage 1: T1 to T5). However, there was a significant increase in G5 IL-10 serum levels starting at Stage 1, T4 to T5 (p<0.001) ( Table 1) .
In Stage 2, G5 IL-10 serum levels at T6 and T7 were significantly higher (p<0.001) ( Tables 1 and 2 show that IL-10 levels were higher in G1, G2, G3, G4, G5 and G7 (p<0.001) than in G6. Groups G3, G4 and G5 showed the highest levels (p<0.001) at T6 and T7, but G5 IL-10 dropped significantly at T8 (p<0.001). The only infected groups that maintained high IL-10 levels were G3 and G4 (p<0.001). G1, G2 and G7 also showed significantly higher levels of IL-10 than G6. However, in G2, the levels were higher than in G1, starting at T8 (p<0.001). The lowest IL-10 means throughout the experiment were seen in G6, G1 and G7. , and 5 th day after T. gondii infection. Different uppercase letters indicate significant differences between groups (p<0.05). Different lowercase letters indicate significant differences among times after infection (p<0.05). G1 -T. gondii infected; G2 -T. gondii infected treated with sulfadiazine; G3 -T. gondii infected immunostimulated with glucan; G4 -T. gondii infected, immunostimulated with glucan, and treated with sulfadiazine; G5 -Glucan; G6 -Saline; and G7 -Sulfadiazine, post infection (Stage 2)
Comparison between groups at each time: T6  T7  T8  T9  T10   Hypothesis  G5=G6  G5=G6  G5=G6  G5=G6 Therefore, the β-glucans can interact with these cells through specific receptors; these include CR3, lactosylceramide, scavenger receptors, and Dectin-1 (5 (42) and in IFN-γ in leishmaniosis patients who received glucan weekly (41) .
In recent studies, Marcondes-Machado (40), using a similar experimental model, found that glucan immunostimulated animals infected by a virulent T. gondii strain showed elevated levels of cytokines such as IFN-γ, IL-12, and TNF-α. This author has also demonstrated that the highest TNF-α levels were detected at the end of infection; this increase was followed by the animal death.
In this study, sulfadiazine-only treatment [G7] was also capable of stimulating IL-10
production. There is evidence that T cells are responsible for initiating and regulating the specific immune response to drugs (4, 25) . These drugs can interact with T cell The very high IL-10 levels obtained in mice with acute T. gondii infection and treated with sulfadiazine [G2] can be explained by the double stimulus they received: on one hand, sulfadiazine inducing IL-10 production as already suggested; and on the other, the protozoa, which despite sulpha parasiticide action, still persist. Piketty et al. (50) reported that sulfamethoxazole reduces T. gondii parasitic load in mouse tissue.
Other authors, investigating the effects of sulfadiazine treatment in BALB/c mice infected with the avirulent strain, detected a decrease in the parasitic load of organs such as the spleen, liver, and lung. However, there was no parasite reduction in the heart, brain, and skin (3). This suggests that the anti-toxoplasmic effects of the drug cannot be simply attributed to its direct effect against the parasite, but to its cooperation with other host defense mechanisms as well as to INF-γ (3, 50).
In the same way, the triple stimulus of acute T. gondii infection, β-glucan immunostimulation, and sulfadiazine treatment [G4] can explain the permanently elevated IL-10 levels. Although high levels of IL-10 were observed in animals treated with glucan, further studies are necessary to confirm its role as immunomodulator over Th1 cytokines production.
